Preventing Osteoporosis, Sarcopenia and Obesity to Care about Quality of Life [PDF]
Annals of Geriatric Medicine and Research, 2023 A recent review by Kumari and Khanna examined the prevalence of sarcopenic obesity using various comorbidities, diagnostic markers, and possible therapeutic approaches. The authors discussed the strong impact of sarcopenic obesity on quality of life (QoL)
Stefano Cacciatore +2 more
doaj +1 more source
Association of serum vitamin D with osteosarcopenic obesity: Korea National Health and Nutrition Examination Survey 2008–2010 [PDF]
Journal of Cachexia, Sarcopenia and Muscle, 2017 Yunhwan Lee +2 more
exaly +2 more sources
Inflammaging in the pathogenesis of chronic noncommunicable diseases
Кардиоваскулярная терапия и профилактика, 2021 See Krivoshapova K. E., Masenko V. L., Bazdyrev E. D., Barbarash O. L. Osteosarcopenic obesity in cardiovascular patients. Controversial and open issues in Review articles, pp. 9298.
O. T. Kim
doaj +1 more source
Coexistence of osteoporosis, sarcopenia and obesity in community-dwelling adults – The Yishun Study
Osteoporosis and Sarcopenia, 2021 Objectives: To 1) report prevalence of ‘osteosarcopenia’ (OS) and osteosarcopenic obesity (OSO) entities using evidence-based diagnostic techniques and definitions, 2) examine if OSO offers additional predictive value of functional decline over its ...
Benedict Wei Jun Pang +9 more
doaj +1 more source
Relationship between osteosarcopenic obesity and dietary inflammatory index in postmenopausal Korean women: 2009 to 2011 Korea National Health and Nutrition Examination Surveys [PDF]
Journal of Clinical Biochemistry and Nutrition, 2018 Woori Na, Cheongmin Sohn
exaly +2 more sources
A Clinical Study of Structural Properties of Osteosarcopenic Obesity Syndrome Using Multivariate Statistical Methods [PDF]
Zhongguo quanke yixue, 2022 Background Osteosarcopenic obesity syndrome (OSO) is a disease that seriously endangers the health of older people. The rational classification of the disease can guide the clinical diagnosis and treatment.
Yizhen NIE, Zhaoqi YAN, Wei YAN, Hongmei FU, Xingjuan ZHAO, Hui YIN, Qunhong WU
doaj +1 more source
Metabolites, 2023 Adiposity is central to aging and several chronic diseases. Adiposity encompasses not just the excess adipose tissue but also body fat redistribution, fat infiltration, hypertrophy of adipocytes, and the shifting of mesenchymal stem cell commitment to ...
Kelsey Hu +9 more
doaj +1 more source
Association Between Sarcopenia and Fracture Risk in a Population From the UK Biobank Database
Journal of Bone and Mineral Research, Volume 38, Issue 10, Page 1422-1434, October 2023., 2023 ABSTRACT Studies on the fracture risk in presarcopenic and sarcopenic patients report contradictory results. The objective was to assess whether presarcopenia and sarcopenia are associated with an increase in fracture risk. We conducted a retrospective study using the UK Biobank cohort and the European Working Group on Sarcopenia in Older People 2 ...
Charlotte Jauffret +5 more
wiley +1 more source
Weight‐adjusted waist as an integrated index for fat, muscle and bone health in adults
Journal of Cachexia, Sarcopenia and Muscle, Volume 14, Issue 5, Page 2196-2203, October 2023., 2023 Abstract Background Unhealthy body composition, including high fat mass, low muscle mass and low bone mass, is a critical health issue in adults. The weight‐adjusted waist index (WWI) estimates fat and muscle mass and may have implications for bone health.
Kyoung Jin Kim +4 more
wiley +1 more source
Sarcopenic obesity in liver disease: Handling both sides of the penny
Portal Hypertension &Cirrhosis, Volume 1, Issue 1, Page 42-56, June 2022., 2022 The multifactorial and complicated pathogenesis of sarcopenic obesity in the context of liver diseases. Abstract Skeletal muscle and fat tissue show distinct pathophysiological roles and pivotal functions. The culmination of muscle wasting and fat accumulation represents an opposite terminal of each state.
Yangyang Hui +10 more
wiley +1 more source